Viewing Study NCT07294534

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 2:29 AM

Ignite Modification Date: 2025-12-26 @ 7:08 PM

Study NCT ID: NCT07294534

Status: NOT_YET_RECRUITING

Last Update Posted: 2025-12-19

First Post: 2025-12-08

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: A Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX87in Combination With HLX22 or Pertuzumab in the Neoadjuvant Therapy of HER2-Positive Bresat Cancer

Sponsor: Shanghai Henlius Biotech

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module